Safety and Immunogenicity of COVID-19 BBIBP-CorV Vaccine in Children 3-12 Years Old
Vaccines This article evaluates the reactogenicity, and immunogenicity of BBIBP-CorV, prior to involving this age group in the vaccination program against COVID-19 in the kingdom of Bahrain. Journal Article
Read More